Stock 688198 BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Beijing Balance Medical Technology Co.,Ltd.

Equities

688198

CNE100005X15

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 29/05/2024 am IST 		5-day change 1st Jan Change
112.2 CNY +5.81% Intraday chart for Beijing Balance Medical Technology Co.,Ltd. +0.87% -9.90%
22/04 Beijing Balance Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
28/02 Balance Medical Technology's Profit Jumps 21% in 2023 MT

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • With an expected P/E ratio at 95.08 and 69.69 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-9.90% 2B - -
STRYKER CORPORATION Stock Stryker Corporation
+13.92% 129B
A-
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-9.11% 10.92B
A-
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
-3.68% 8.5B
C
GLAUKOS CORPORATION Stock Glaukos Corporation
+38.81% 5.5B
B+
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-21.15% 4.69B
C
AXONICS, INC. Stock Axonics, Inc.
+7.67% 3.42B
C-
ENOVIS CORPORATION Stock Enovis Corporation
-11.71% 2.73B
B-
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-13.94% 1.93B -
DOUBLE MEDICAL TECHNOLOGY INC. Stock Double Medical Technology Inc.
-28.58% 1.65B
C-
Investor Rating
-
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
-
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. 688198 Stock
  4. Ratings Beijing Balance Medical Technology Co.,Ltd.